Lowenthal Richard E

ARS Pharmaceuticals, Inc. · PRESIDENT AND CEO

Lowenthal Richard E is listed in filings as PRESIDENT AND CEO at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY). The current snapshot covers public activity from Jun 13, 2024 to Jan 5, 2026. Reported amounts are shown as $437.5K to $439.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
ARS Pharmaceuticals, Inc.SPRY$437k47.8k sharesSellJun 12, 2024$9.15$7.46
ARS Pharmaceuticals, Inc.SPRY$19k2.2k sharesSellJun 11, 2024$9.00$7.46
ARS Pharmaceuticals, Inc.SPRY$439k48k sharesSellJun 12, 2024$9.14$7.46
ARS Pharmaceuticals, Inc.SPRY$18k2k sharesSellJun 11, 2024$9.00$7.46
ARS Pharmaceuticals, Inc.SPRY$481k50k sharesSellJul 9, 2024$9.62$7.46
ARS Pharmaceuticals, Inc.SPRY$481k50k sharesSellJul 9, 2024$9.62$7.46
ARS Pharmaceuticals, Inc.SPRY$570k50k sharesSellJul 16, 2024$11.40$7.46
ARS Pharmaceuticals, Inc.SPRY$570k50k sharesSellJul 16, 2024$11.40$7.46
ARS Pharmaceuticals, Inc.SPRY$452k35.4k sharesSellAug 13, 2024$12.76$7.46
ARS Pharmaceuticals, Inc.SPRY$172k14.6k sharesSellAug 13, 2024$11.78$7.46
ARS Pharmaceuticals, Inc.SPRY$451k35.4k sharesSellAug 13, 2024$12.77$7.46
ARS Pharmaceuticals, Inc.SPRY$172k14.6k sharesSellAug 13, 2024$11.77$7.46
ARS Pharmaceuticals, Inc.SPRY$37k2.3k sharesSellAug 20, 2024$16.26$7.46
ARS Pharmaceuticals, Inc.SPRY$37k2.3k sharesSellAug 20, 2024$16.25$7.46
ARS Pharmaceuticals, Inc.SPRY$184k11.8k sharesSellAug 20, 2024$15.61$7.46
ARS Pharmaceuticals, Inc.SPRY$180k11.5k sharesSellAug 20, 2024$15.62$7.46
ARS Pharmaceuticals, Inc.SPRY$530k35.9k sharesSellAug 20, 2024$14.76$7.46
ARS Pharmaceuticals, Inc.SPRY$534k36.2k sharesSellAug 20, 2024$14.76$7.46
ARS Pharmaceuticals, Inc.SPRY$575k50k sharesSellSep 10, 2024$11.50$7.46
ARS Pharmaceuticals, Inc.SPRY$575k50k sharesSellSep 10, 2024$11.50$7.46
ARS Pharmaceuticals, Inc.SPRY$647k50k sharesSellSep 17, 2024$12.93$7.46
ARS Pharmaceuticals, Inc.SPRY$647k50k sharesSellSep 17, 2024$12.93$7.46
ARS Pharmaceuticals, Inc.SPRY$691k50k sharesSellOct 8, 2024$13.83$7.46
ARS Pharmaceuticals, Inc.SPRY$691k50k sharesSellOct 8, 2024$13.83$7.46
ARS Pharmaceuticals, Inc.SPRY$744k50k sharesSellOct 15, 2024$14.88$7.46
ARS Pharmaceuticals, Inc.SPRY$22k1.5k sharesSellOct 15, 2024$15.25$7.46
ARS Pharmaceuticals, Inc.SPRY$722k48.6k sharesSellOct 15, 2024$14.86$7.46
ARS Pharmaceuticals, Inc.SPRY$86k4.9k sharesSellNov 12, 2024$17.64$7.46
ARS Pharmaceuticals, Inc.SPRY$756k45.1k sharesSellNov 12, 2024$16.76$7.46
ARS Pharmaceuticals, Inc.SPRY$87k5k sharesSellNov 12, 2024$17.64$7.46
ARS Pharmaceuticals, Inc.SPRY$755k45k sharesSellNov 12, 2024$16.76$7.46
ARS Pharmaceuticals, Inc.SPRY$697k50k sharesSellNov 19, 2024$13.95$7.46
ARS Pharmaceuticals, Inc.SPRY$698k50k sharesSellNov 19, 2024$13.95$7.46
ARS Pharmaceuticals, Inc.SPRY$658k50k sharesSellDec 10, 2024$13.16$7.46
ARS Pharmaceuticals, Inc.SPRY$658k50k sharesSellDec 10, 2024$13.17$7.46
ARS Pharmaceuticals, Inc.SPRY$584k50k sharesSellDec 17, 2024$11.67$7.46
ARS Pharmaceuticals, Inc.SPRY$584k50k sharesSellDec 17, 2024$11.67$7.46